Literature DB >> 22891124

Transcatheter aortic valve replacement (TAVR): access planning and strategies.

Basel Ramlawi1, Javier E Anaya-Ayala, Michael J Reardon.   

Abstract

Transcatheter aortic valve replacement (TAVR) has proven to be a viable tool for the high-surgical-risk population with severe aortic valve stenosis. Vascular access complications are not uncommon with TAVR and may increase early and late mortality. Avoiding these serious complications is the goal. With experience and careful screening, we are now able to risk-stratify patients who may be at increased risk of vascular complications. While the traditional iliofemoral access site remains the most common for TAVR, alternate access sites that have proven to be viable and safe alternatives include the transapical, direct-aortic, and subclavian techniques. TAVR teams should be familiar and comfortable with these approaches as each of them has its own advantages and weaknesses. The best option is usually one in which the procedure is tailored to the patient. The present review examines our current access planning and strategies for TAVR.

Entities:  

Keywords:  Edwards SAPIEN valve; Medtronic CoreValve; PARTNER trial; ProGlide device; TAVI; TAVI access; aortic stenosis; femoral access; iliofemoral access; transcatheter aortic valve replacement

Mesh:

Year:  2012        PMID: 22891124      PMCID: PMC3405802          DOI: 10.14797/mdcj-8-2-22

Source DB:  PubMed          Journal:  Methodist Debakey Cardiovasc J        ISSN: 1947-6108


  9 in total

1.  Direct aortic access through right minithoracotomy for implantation of self-expanding aortic bioprosthetic valves.

Authors:  Giuseppe Bruschi; Federico De Marco; Pasquale Fratto; Jacopo Oreglia; Paola Colombo; Roberto Paino; Silvio Klugmann; Luigi Martinelli
Journal:  J Thorac Cardiovasc Surg       Date:  2010-04-14       Impact factor: 5.209

2.  Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.

Authors:  Martin B Leon; Craig R Smith; Michael Mack; D Craig Miller; Jeffrey W Moses; Lars G Svensson; E Murat Tuzcu; John G Webb; Gregory P Fontana; Raj R Makkar; David L Brown; Peter C Block; Robert A Guyton; Augusto D Pichard; Joseph E Bavaria; Howard C Herrmann; Pamela S Douglas; John L Petersen; Jodi J Akin; William N Anderson; Duolao Wang; Stuart Pocock
Journal:  N Engl J Med       Date:  2010-09-22       Impact factor: 91.245

3.  Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium.

Authors:  Martin B Leon; Nicolo Piazza; Eugenia Nikolsky; Eugene H Blackstone; Donald E Cutlip; Arie Pieter Kappetein; Mitchell W Krucoff; Michael Mack; Roxana Mehran; Craig Miller; Marie-angéle Morel; John Petersen; Jeffrey J Popma; Johanna J M Takkenberg; Alec Vahanian; Gerrit-Anne van Es; Pascal Vranckx; John G Webb; Stephan Windecker; Patrick W Serruys
Journal:  J Am Coll Cardiol       Date:  2011-01-07       Impact factor: 24.094

4.  2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.

Authors:  Robert O Bonow; Blase A Carabello; Kanu Chatterjee; Antonio C de Leon; David P Faxon; Michael D Freed; William H Gaasch; Bruce W Lytle; Rick A Nishimura; Patrick T O'Gara; Robert A O'Rourke; Catherine M Otto; Pravin M Shah; Jack S Shanewise; Rick A Nishimura; Blase A Carabello; David P Faxon; Michael D Freed; Bruce W Lytle; Patrick T O'Gara; Robert A O'Rourke; Pravin M Shah
Journal:  J Am Coll Cardiol       Date:  2008-09-23       Impact factor: 24.094

5.  Expanding the eligibility for transcatheter aortic valve implantation the trans-subclavian retrograde approach using: the III generation CoreValve revalving system.

Authors:  Chiara Fraccaro; Massimo Napodano; Giuseppe Tarantini; Valeria Gasparetto; Gino Gerosa; Roberto Bianco; Raffaele Bonato; Demetrio Pittarello; Giambattista Isabella; Sabino Iliceto; Angelo Ramondo
Journal:  JACC Cardiovasc Interv       Date:  2009-09       Impact factor: 11.195

6.  Transcatheter versus surgical aortic-valve replacement in high-risk patients.

Authors:  Craig R Smith; Martin B Leon; Michael J Mack; D Craig Miller; Jeffrey W Moses; Lars G Svensson; E Murat Tuzcu; John G Webb; Gregory P Fontana; Raj R Makkar; Mathew Williams; Todd Dewey; Samir Kapadia; Vasilis Babaliaros; Vinod H Thourani; Paul Corso; Augusto D Pichard; Joseph E Bavaria; Howard C Herrmann; Jodi J Akin; William N Anderson; Duolao Wang; Stuart J Pocock
Journal:  N Engl J Med       Date:  2011-06-05       Impact factor: 91.245

7.  Transaortic transcatheter aortic valve implantation: a novel approach for the truly "no-access option" patients.

Authors:  George Latsios; Ulrich Gerckens; Eberhard Grube
Journal:  Catheter Cardiovasc Interv       Date:  2010-06-01       Impact factor: 2.692

8.  Safety and efficacy of the subclavian approach for transcatheter aortic valve implantation with the CoreValve revalving system.

Authors:  Anna Sonia Petronio; Marco De Carlo; Francesco Bedogni; Antonio Marzocchi; Silvio Klugmann; Francesco Maisano; Angelo Ramondo; Gian Paolo Ussia; Federica Ettori; Arnaldo Poli; Nedy Brambilla; Francesco Saia; Federico De Marco; Antonio Colombo
Journal:  Circ Cardiovasc Interv       Date:  2010-07-06       Impact factor: 6.546

9.  Midterm outcomes of femoral arteries after percutaneous endovascular aortic repair using the Preclose technique.

Authors:  W Anthony Lee; Michael P Brown; Peter R Nelson; Thomas S Huber; James M Seeger
Journal:  J Vasc Surg       Date:  2008-03-06       Impact factor: 4.268

  9 in total
  9 in total

Review 1.  Percutaneous or surgical access for transfemoral transcatheter aortic valve implantation.

Authors:  Amit N Vora; Sunil V Rao
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

2.  Improved Registration of 3D CT Angiography with X-ray Fluoroscopy for Image Fusion During Transcatheter Aortic Valve Implantation.

Authors:  Ina Vernikouskaya; Wolfgang Rottbauer; Julia Seeger; Birgid Gonska; Jochen Wöhrle; Volker Rasche
Journal:  J Vis Exp       Date:  2018-06-03       Impact factor: 1.355

Review 3.  A Review of Alternative Access for Transcatheter Aortic Valve Replacement.

Authors:  Michael N Young; Vikas Singh; Rahul Sakhuja
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-07-04

Review 4.  The Crucial Role of Cardiac Imaging in Transcatheter Aortic Valve Replacement (TAVR): Pre- and Post-procedural Assessment.

Authors:  Saif Al-Najafi; Frank Sanchez; Stamatios Lerakis
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-12

Review 5.  Preinterventional screening of the TAVI patient: how to choose the suitable patient and the best procedure.

Authors:  Crochan J O'Sullivan; Stefan Stortecky; Lutz Buellesfeld; Peter Wenaweser; Stephan Windecker
Journal:  Clin Res Cardiol       Date:  2014-02-11       Impact factor: 5.460

Review 6.  Cardiovascular Collapse During Transcatheter Aortic Valve Replacement: Diagnosis and Treatment of the "Perilous Pentad".

Authors:  Adam El-Gamel
Journal:  Aorta (Stamford)       Date:  2013-12-01

7.  Patient-specific registration of 3D CT angiography (CTA) with X-ray fluoroscopy for image fusion during transcatheter aortic valve implantation (TAVI) increases performance of the procedure.

Authors:  I Vernikouskaya; W Rottbauer; J Seeger; B Gonska; V Rasche; Jochen Wöhrle
Journal:  Clin Res Cardiol       Date:  2018-02-16       Impact factor: 5.460

8.  Impact of sheath diameter of different sheath types on vascular complications and mortality in transfemoral TAVI approaches using the Proglide closure device.

Authors:  Zisis Dimitriadis; Werner Scholtz; Stephan M Ensminger; Cornelia Piper; Thomas Bitter; Marcus Wiemer; Marios Vlachojannis; Jochen Börgermann; Lothar Faber; Dieter Horstkotte; Jan Gummert; Smita Scholtz
Journal:  PLoS One       Date:  2017-08-24       Impact factor: 3.240

9.  Factors Associated with Discharge to a Skilled Nursing Facility after Transcatheter Aortic Valve Replacement Surgery.

Authors:  Carolyn E Horne; Tamara S Goda; L Wiley Nifong; Alan P Kypson; Wesley T O'Neal; Linda C Kindell; Charulata Jindal; Jimmy T Efird
Journal:  Int J Environ Res Public Health       Date:  2018-12-28       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.